Cargando…
Common variants at 2q37.3, 8q24.21, 15q21.3, and 16q24.1 influence chronic lymphocytic leukemia risk
To identify novel risk variants for chronic lymphocytic leukemia (CLL) we conducted a genome-wide association study of 299,983 tagging SNPs, with validation in four additional series totaling 2,503 cases and 5,789 controls. We identified four risk loci for CLL at 2q37.3 (rs757978, FARP2; odds ratio...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5321238/ https://www.ncbi.nlm.nih.gov/pubmed/20062064 http://dx.doi.org/10.1038/ng.510 |
_version_ | 1782509655927291904 |
---|---|
author | Crowther-Swanepoel, Dalemari Broderick, Peter Di Bernardo, Maria Chiara Dobbins, Sara E Torres, María Mansouri, Mahmoud Ruiz-Ponte, Clara Enjuanes, Anna Rosenquist, Richard Carracedo, Angel Jurlander, Jesper Campo, Elias Juliusson, Gunnar Montserrat, Emilio Smedby, Karin E Dyer, Martin JS Matutes, Estella Dearden, Claire Sunter, Nicola J Hall, Andrew G Mainou-Fowler, Tryfonia Jackson, Graham H Summerfield, Geoffrey Harris, Robert J Pettitt, Andrew R Allsup, David J Bailey, James R Pratt, Guy Pepper, Chris Fegan, Chris Parker, Anton Oscier, David Allan, James M Catovsky, Daniel Houlston, Richard S |
author_facet | Crowther-Swanepoel, Dalemari Broderick, Peter Di Bernardo, Maria Chiara Dobbins, Sara E Torres, María Mansouri, Mahmoud Ruiz-Ponte, Clara Enjuanes, Anna Rosenquist, Richard Carracedo, Angel Jurlander, Jesper Campo, Elias Juliusson, Gunnar Montserrat, Emilio Smedby, Karin E Dyer, Martin JS Matutes, Estella Dearden, Claire Sunter, Nicola J Hall, Andrew G Mainou-Fowler, Tryfonia Jackson, Graham H Summerfield, Geoffrey Harris, Robert J Pettitt, Andrew R Allsup, David J Bailey, James R Pratt, Guy Pepper, Chris Fegan, Chris Parker, Anton Oscier, David Allan, James M Catovsky, Daniel Houlston, Richard S |
author_sort | Crowther-Swanepoel, Dalemari |
collection | PubMed |
description | To identify novel risk variants for chronic lymphocytic leukemia (CLL) we conducted a genome-wide association study of 299,983 tagging SNPs, with validation in four additional series totaling 2,503 cases and 5,789 controls. We identified four risk loci for CLL at 2q37.3 (rs757978, FARP2; odds ratio [OR] = 1.39; P = 2.11 x 10(-9)), 8q24.21 (rs2456449; OR = 1.26; P = 7.84 x 10(-10)), 15q21.3 (rs7169431; OR = 1.36; P = 4.74 x 10(-7)) and 16q24.1 (rs305061; OR = 1.22; P = 3.60 x 10(-7)). There was also evidence for risk loci at 15q25.2 (rs783540, CPEB1; OR = 1.18; P = 3.67 x 10(-6)) and 18q21.1 (rs1036935; OR = 1.22; P = 2.28 x 10(-6)). These data provide further evidence for genetic susceptibility to this B-cell hematological malignancy. |
format | Online Article Text |
id | pubmed-5321238 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
record_format | MEDLINE/PubMed |
spelling | pubmed-53212382017-02-22 Common variants at 2q37.3, 8q24.21, 15q21.3, and 16q24.1 influence chronic lymphocytic leukemia risk Crowther-Swanepoel, Dalemari Broderick, Peter Di Bernardo, Maria Chiara Dobbins, Sara E Torres, María Mansouri, Mahmoud Ruiz-Ponte, Clara Enjuanes, Anna Rosenquist, Richard Carracedo, Angel Jurlander, Jesper Campo, Elias Juliusson, Gunnar Montserrat, Emilio Smedby, Karin E Dyer, Martin JS Matutes, Estella Dearden, Claire Sunter, Nicola J Hall, Andrew G Mainou-Fowler, Tryfonia Jackson, Graham H Summerfield, Geoffrey Harris, Robert J Pettitt, Andrew R Allsup, David J Bailey, James R Pratt, Guy Pepper, Chris Fegan, Chris Parker, Anton Oscier, David Allan, James M Catovsky, Daniel Houlston, Richard S Nat Genet Article To identify novel risk variants for chronic lymphocytic leukemia (CLL) we conducted a genome-wide association study of 299,983 tagging SNPs, with validation in four additional series totaling 2,503 cases and 5,789 controls. We identified four risk loci for CLL at 2q37.3 (rs757978, FARP2; odds ratio [OR] = 1.39; P = 2.11 x 10(-9)), 8q24.21 (rs2456449; OR = 1.26; P = 7.84 x 10(-10)), 15q21.3 (rs7169431; OR = 1.36; P = 4.74 x 10(-7)) and 16q24.1 (rs305061; OR = 1.22; P = 3.60 x 10(-7)). There was also evidence for risk loci at 15q25.2 (rs783540, CPEB1; OR = 1.18; P = 3.67 x 10(-6)) and 18q21.1 (rs1036935; OR = 1.22; P = 2.28 x 10(-6)). These data provide further evidence for genetic susceptibility to this B-cell hematological malignancy. 2010-01-10 2010-02 /pmc/articles/PMC5321238/ /pubmed/20062064 http://dx.doi.org/10.1038/ng.510 Text en http://www.nature.com/authors/editorial_policies/license.html#terms Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms |
spellingShingle | Article Crowther-Swanepoel, Dalemari Broderick, Peter Di Bernardo, Maria Chiara Dobbins, Sara E Torres, María Mansouri, Mahmoud Ruiz-Ponte, Clara Enjuanes, Anna Rosenquist, Richard Carracedo, Angel Jurlander, Jesper Campo, Elias Juliusson, Gunnar Montserrat, Emilio Smedby, Karin E Dyer, Martin JS Matutes, Estella Dearden, Claire Sunter, Nicola J Hall, Andrew G Mainou-Fowler, Tryfonia Jackson, Graham H Summerfield, Geoffrey Harris, Robert J Pettitt, Andrew R Allsup, David J Bailey, James R Pratt, Guy Pepper, Chris Fegan, Chris Parker, Anton Oscier, David Allan, James M Catovsky, Daniel Houlston, Richard S Common variants at 2q37.3, 8q24.21, 15q21.3, and 16q24.1 influence chronic lymphocytic leukemia risk |
title | Common variants at 2q37.3, 8q24.21, 15q21.3, and 16q24.1 influence chronic lymphocytic leukemia risk |
title_full | Common variants at 2q37.3, 8q24.21, 15q21.3, and 16q24.1 influence chronic lymphocytic leukemia risk |
title_fullStr | Common variants at 2q37.3, 8q24.21, 15q21.3, and 16q24.1 influence chronic lymphocytic leukemia risk |
title_full_unstemmed | Common variants at 2q37.3, 8q24.21, 15q21.3, and 16q24.1 influence chronic lymphocytic leukemia risk |
title_short | Common variants at 2q37.3, 8q24.21, 15q21.3, and 16q24.1 influence chronic lymphocytic leukemia risk |
title_sort | common variants at 2q37.3, 8q24.21, 15q21.3, and 16q24.1 influence chronic lymphocytic leukemia risk |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5321238/ https://www.ncbi.nlm.nih.gov/pubmed/20062064 http://dx.doi.org/10.1038/ng.510 |
work_keys_str_mv | AT crowtherswanepoeldalemari commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk AT broderickpeter commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk AT dibernardomariachiara commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk AT dobbinssarae commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk AT torresmaria commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk AT mansourimahmoud commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk AT ruizponteclara commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk AT enjuanesanna commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk AT rosenquistrichard commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk AT carracedoangel commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk AT jurlanderjesper commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk AT campoelias commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk AT juliussongunnar commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk AT montserratemilio commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk AT smedbykarine commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk AT dyermartinjs commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk AT matutesestella commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk AT deardenclaire commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk AT sunternicolaj commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk AT hallandrewg commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk AT mainoufowlertryfonia commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk AT jacksongrahamh commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk AT summerfieldgeoffrey commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk AT harrisrobertj commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk AT pettittandrewr commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk AT allsupdavidj commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk AT baileyjamesr commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk AT prattguy commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk AT pepperchris commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk AT feganchris commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk AT parkeranton commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk AT oscierdavid commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk AT allanjamesm commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk AT catovskydaniel commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk AT houlstonrichards commonvariantsat2q3738q242115q213and16q241influencechroniclymphocyticleukemiarisk |